See more : HFCL Limited (HFCL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Linical Co., Ltd. (2183.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Linical Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Jumia Technologies AG (JMIA) Income Statement Analysis – Financial Results
- Alankit Limited (ALANKIT.NS) Income Statement Analysis – Financial Results
- NeuroPace, Inc. (NPCE) Income Statement Analysis – Financial Results
- Investeringsforeningen C Worldwide Indien Kl (CWIIA.CO) Income Statement Analysis – Financial Results
- W.W. Grainger, Inc. (0IZI.L) Income Statement Analysis – Financial Results
Linical Co., Ltd. (2183.T)
About Linical Co., Ltd.
Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.31B | 12.52B | 11.56B | 10.28B | 10.94B | 11.31B | 9.11B | 8.36B | 7.67B | 4.87B | 3.72B | 3.60B | 3.11B | 2.51B | 2.40B | 2.04B | 1.27B |
| Cost of Revenue | 8.53B | 8.36B | 7.94B | 7.51B | 7.40B | 7.50B | 5.58B | 4.69B | 4.21B | 3.08B | 2.30B | 1.95B | 1.76B | 1.55B | 1.34B | 912.46M | 504.35M |
| Gross Profit | 3.78B | 4.16B | 3.61B | 2.77B | 3.53B | 3.81B | 3.53B | 3.67B | 3.45B | 1.79B | 1.42B | 1.65B | 1.35B | 962.04M | 1.07B | 1.12B | 768.69M |
| Gross Profit Ratio | 30.69% | 33.25% | 31.26% | 26.92% | 32.29% | 33.70% | 38.77% | 43.90% | 45.05% | 36.70% | 38.17% | 45.95% | 43.53% | 38.30% | 44.36% | 55.18% | 60.38% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 404.00M | 436.00M | 426.00M | 478.00M | 487.00M | 483.00M | 1.69B | 378.00M | 358.00M | 345.00M | 339.00M | 291.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 2.30B | 2.07B | 1.76B | 1.54B | 1.68B | 1.71B | 0.00 | 1.01B | 984.09M | 517.00M | 375.00M | 359.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.71B | 2.51B | 2.19B | 2.02B | 2.17B | 2.19B | 1.69B | 1.39B | 1.34B | 862.00M | 714.00M | 650.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 347.00M | -78.55M | -1.11M | 122.94M | -8.00M | -4.72M | 1.09M | -1.06M | -1.04M | 157.00K | 111.00K | -173.00K | 11.00K | 38.00K | -5.47M | -31.17M | -11.50M |
| Operating Expenses | 3.05B | 2.91B | 2.53B | 2.31B | 2.53B | 2.60B | 1.69B | 1.54B | 1.44B | 911.45M | 714.47M | 650.68M | 625.27M | 673.19M | 585.83M | 573.98M | 263.60M |
| Cost & Expenses | 11.58B | 11.26B | 10.47B | 9.83B | 9.93B | 10.10B | 7.27B | 6.23B | 5.65B | 4.00B | 3.02B | 2.60B | 2.38B | 2.22B | 1.92B | 1.49B | 767.95M |
| Interest Income | 52.27M | 1.81M | 598.00K | 10.22M | 1.21M | 1.61M | 605.00K | 3.33M | 4.81M | 1.01M | 1.51M | 608.00K | 218.00K | 288.00K | 434.00K | 1.10M | 1.14M |
| Interest Expense | 17.64M | 12.83M | 14.18M | 15.41M | 15.17M | 13.49M | 4.34M | 5.19M | 8.09M | 5.93M | 4.59M | 5.54M | 5.38M | 3.40M | 1.74M | 1.85M | 566.00K |
| Depreciation & Amortization | 521.51M | 503.35M | 458.78M | 427.25M | 463.32M | 451.29M | 210.39M | 202.93M | 187.19M | 80.48M | 12.85M | 19.76M | 26.84M | 32.50M | 23.62M | 14.76M | 803.00K |
| EBITDA | 1.20B | 1.89B | 1.50B | 801.38M | 1.29B | 1.63B | 2.04B | 2.22B | 2.18B | 828.79M | 724.36M | 1.03B | 758.92M | 314.51M | 501.93M | 532.61M | 503.49M |
| EBITDA Ratio | 9.74% | 14.49% | 14.08% | 9.96% | 12.88% | 15.24% | 22.46% | 27.25% | 28.59% | 19.03% | 19.38% | 28.44% | 24.30% | 12.52% | 20.77% | 26.16% | 38.93% |
| Operating Income | 725.72M | 1.26B | 1.09B | 453.43M | 1.01B | 1.21B | 1.85B | 2.13B | 2.01B | 876.72M | 706.20M | 1.00B | 728.73M | 288.85M | 480.75M | 549.56M | 505.09M |
| Operating Income Ratio | 5.90% | 10.04% | 9.40% | 4.41% | 9.19% | 10.72% | 20.26% | 25.48% | 26.25% | 17.99% | 18.97% | 27.88% | 23.43% | 11.50% | 20.00% | 26.99% | 39.68% |
| Total Other Income/Expenses | -65.49M | 121.92M | -53.96M | -94.71M | -197.00M | -48.74M | -20.22M | -118.08M | -26.52M | -141.73M | -2.32M | -5.10M | -5.15M | -10.24M | -6.78M | -33.57M | -2.97M |
| Income Before Tax | 660.23M | 1.38B | 1.03B | 358.73M | 808.24M | 1.16B | 1.83B | 2.01B | 1.99B | 734.99M | 703.88M | 998.19M | 723.58M | 278.61M | 473.97M | 515.99M | 502.12M |
| Income Before Tax Ratio | 5.36% | 11.01% | 8.93% | 3.49% | 7.39% | 10.29% | 20.04% | 24.06% | 25.90% | 15.09% | 18.91% | 27.73% | 23.26% | 11.09% | 19.71% | 25.34% | 39.44% |
| Income Tax Expense | 321.96M | 374.25M | 241.45M | -181.24M | 325.25M | 595.77M | 530.48M | 563.07M | 654.94M | 297.85M | 254.70M | 381.40M | 299.38M | 130.72M | 200.36M | 215.51M | 206.44M |
| Net Income | 338.27M | 1.00B | 790.49M | 539.97M | 482.99M | 568.46M | 1.30B | 1.45B | 1.33B | 437.14M | 449.19M | 616.79M | 424.20M | 147.89M | 273.61M | 300.48M | 296.58M |
| Net Income Ratio | 2.75% | 8.02% | 6.84% | 5.25% | 4.42% | 5.02% | 14.22% | 17.32% | 17.36% | 8.97% | 12.07% | 17.14% | 13.64% | 5.89% | 11.38% | 14.76% | 23.30% |
| EPS | 14.98 | 44.47 | 35.00 | 23.91 | 21.38 | 25.09 | 57.02 | 63.59 | 58.40 | 19.18 | 19.71 | 27.07 | 18.61 | 6.19 | 11.08 | 12.18 | 136.55K |
| EPS Diluted | 14.98 | 44.47 | 35.00 | 23.91 | 21.38 | 25.09 | 57.02 | 63.59 | 58.40 | 19.18 | 19.71 | 27.07 | 18.61 | 6.19 | 11.08 | 12.18 | 136.55K |
| Weighted Avg Shares Out | 22.59M | 22.59M | 22.59M | 22.59M | 22.59M | 22.66M | 22.73M | 22.76M | 22.79M | 22.79M | 22.79M | 22.79M | 22.79M | 23.90M | 24.69M | 24.68M | 2.17K |
| Weighted Avg Shares Out (Dil) | 22.59M | 22.59M | 22.59M | 22.59M | 22.59M | 22.66M | 22.73M | 22.76M | 22.79M | 22.79M | 22.79M | 22.79M | 22.79M | 23.90M | 24.69M | 24.68M | 2.17K |
Source: https://incomestatements.info
Category: Stock Reports